Richard Kovacs to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Richard Kovacs has written about Angiotensin Receptor Antagonists.
Connection Strength
0.195
-
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents. J Am Med Dir Assoc. 2020 Jul; 21(7):909-914.e2.
Score: 0.130
-
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020 05; 26(5):370.
Score: 0.065